ALVEOLAR MACROPHAGE FUNCTION DURING IMMUNOSUPPRESSION
免疫抑制期间的肺泡巨噬细胞功能
基本信息
- 批准号:3340356
- 负责人:
- 金额:$ 13.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1982
- 资助国家:美国
- 起止时间:1982-08-01 至 1993-07-31
- 项目状态:已结题
- 来源:
- 关键词:Pneumocystis T lymphocyte aerosols alveolar macrophages arachidonate cellular immunity cytokine cytotoxicity diagnostic respiratory lavage disease /disorder model glucocorticoids interleukin 1 laboratory rat leukocyte activation /transformation lung disorder particle counter pneumonia radiation immunosuppression receptor respiratory function surface antigens
项目摘要
The overall objective of this project is to define mechanisms for
the regulation of alveolar macrophage function. The current
study will investigate how immunosuppression influences the
functions of alveolar macrophages and what effect this may have
on host defense against opportunistic pulmonary infection. It is
our hypothesis that immunosuppression decreases alveolar
macrophage function and that this decreased function is
important in the pathogenesis of opportunistic infection. The
present proposal will test this hypothesis in the rat, using
glucocorticoid treatment as a model of immunosuppression and
Pneumocystis carinii pneumonia as a model of opportunistic
infection.
Specific Aim 1. To characterize the effects of experimentally-
induced immunosuppression on alveolar macrophage function.
Alveolar macrophages will be recovered from glucocorticoid-
treated rats at serial intervals and examined for functions
relevant to host defense against infection: cytotoxic function,
expression of Ia determinants, elaboration of interleukin-1, and
release of arachidonic acid metabolites. Glucocorticoid-treated
rats will also be monitored for infection with Pneumocystis
carinii, so that changes in the functions of alveolar macrophages
can be correlated with the development of infection.
Specific Aim 2. To examine whether functions of alveolar
macrophages which are decreased during immunosuppression can
be increased in vitro. Alveolar macrophages from glucocorticoid-
treated rats will be cultured in vitro with recombinant interferon
gamma and tumor necrosis factor alpha to see if specific
functions can be increased in response to these cytokines.
Specific Aim 3. To examine whether functions of alveolar
macrophages which are decreased during immunosuppression can
be increased in vivo. Based upon the results of experiments
performed for Specific Aims 1 and 2, glucocorticoid-treated rats
will be exposed to aerosolized cytokines at selected time points.
The functions of lavaged alveolar macrophages will then be
assayed to see if aerosolized cytokines can increase the function
of these cells in vivo.
Specific Aim 4. To examine whether increasing alveolar
macrophage function in vivo can prevent or ameliorate
opportunistic infection of the lungs. Based upon the results of
experiments performed for Specific Aim 3, glucocorticoid-treated
rats will be exposed to aerosolized cytokine(s) and monitored for
infection with Pneumocystis carinii, to see if increasing alveolar
macrophage function in vivo will influence the natural history of
this infection.
The results of these experiments will provide new information as
to how immunosuppression affects specific alveolar macrophage
functions and how this influences host defense against
Pneumocystis carinii. The ability to increase alveolar
macrophage function by aerosol delivery of cytokines may
warrant extension of this work to the study of humans with
immunosuppression and opportunistic pulmonary infections.
该项目的总体目标是定义机制
肺泡巨噬细胞功能的调节。 目前的
研究将调查免疫抑制如何影响
肺泡巨噬细胞的功能及其可能产生的影响
宿主对机会性肺部感染的防御。 这是
我们的假设是免疫抑制会减少肺泡
巨噬细胞功能,这种功能下降是
在机会性感染的发病机制中具有重要意义。 这
目前的提议将在大鼠中测试这一假设,使用
糖皮质激素治疗作为免疫抑制模型
卡氏肺孢子虫肺炎作为机会性肺炎模型
感染。
具体目标 1. 表征实验效果-
诱导肺泡巨噬细胞功能的免疫抑制。
肺泡巨噬细胞将从糖皮质激素中回收-
连续间隔治疗大鼠并检查其功能
与宿主防御感染相关:细胞毒功能,
Ia 决定簇的表达、白介素-1 的详细阐述,以及
花生四烯酸代谢物的释放。 糖皮质激素治疗
还将监测大鼠的肺孢子虫感染情况
carinii,使肺泡巨噬细胞的功能发生变化
可能与感染的发生有关。
具体目的2.检查肺泡功能是否正常
免疫抑制期间巨噬细胞减少
体外增加。 来自糖皮质激素的肺泡巨噬细胞-
治疗后的大鼠将用重组干扰素进行体外培养
γ 和肿瘤坏死因子 α 看看是否有特异性
对这些细胞因子的反应可以增强功能。
具体目的 3. 检查肺泡功能是否正常
免疫抑制期间巨噬细胞减少
体内增加。 根据实验结果
针对具体目标 1 和 2、糖皮质激素治疗的大鼠进行
将在选定的时间点暴露于雾化的细胞因子。
灌洗后的肺泡巨噬细胞的功能将被
检测雾化细胞因子是否可以增强功能
这些细胞在体内。
具体目标 4. 检查肺泡是否增加
体内巨噬细胞功能可以预防或改善
肺部机会性感染。 根据结果
针对特定目标 3 进行的实验,经糖皮质激素处理
大鼠将暴露于雾化细胞因子并监测
卡氏肺囊虫感染,看肺泡是否增大
体内巨噬细胞的功能将影响自然史
这种感染。
这些实验的结果将提供新的信息:
免疫抑制如何影响特定的肺泡巨噬细胞
功能以及这如何影响宿主防御
卡氏肺孢子虫。 增加肺泡的能力
巨噬细胞通过气溶胶递送细胞因子发挥功能
保证将这项工作扩展到对人类的研究
免疫抑制和机会性肺部感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JUDD E SHELLITO其他文献
JUDD E SHELLITO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JUDD E SHELLITO', 18)}}的其他基金
Alcohol-induced Dysbiosis and HIV-associated Pneumonia
酒精引起的生态失调和艾滋病毒相关肺炎
- 批准号:
10023920 - 财政年份:2019
- 资助金额:
$ 13.89万 - 项目类别:
Marrow Stromal Cell Homing to the Lung in Emphysema
肺气肿中骨髓基质细胞归巢至肺
- 批准号:
6968006 - 财政年份:2004
- 资助金额:
$ 13.89万 - 项目类别:
Host Defense Against HIV-related Pulmonary Infections
宿主针对艾滋病毒相关肺部感染的防御
- 批准号:
6852658 - 财政年份:2004
- 资助金额:
$ 13.89万 - 项目类别:
Host Defense Against HIV-related Pulmonary Infections
宿主针对艾滋病毒相关肺部感染的防御
- 批准号:
8529253 - 财政年份:2004
- 资助金额:
$ 13.89万 - 项目类别:
CD4-Dependent help for mucosal vaccine responses
CD4 依赖性有助于粘膜疫苗反应
- 批准号:
8708934 - 财政年份:2004
- 资助金额:
$ 13.89万 - 项目类别:
CD4-Dependent help for mucosal vaccine responses
CD4 依赖性有助于粘膜疫苗反应
- 批准号:
8898873 - 财政年份:2004
- 资助金额:
$ 13.89万 - 项目类别:
Host Defense Against HIV-related Pulmonary Infections
宿主针对艾滋病毒相关肺部感染的防御
- 批准号:
7568965 - 财政年份:2004
- 资助金额:
$ 13.89万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 13.89万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 13.89万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 13.89万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 13.89万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 13.89万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 13.89万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 13.89万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 13.89万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 13.89万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 13.89万 - 项目类别:
Discovery Grants Program - Individual